NEUROD2-related disorder with neonatal onset: case report and review of the literature

Licia Lugli , Isotta Guidotti , Cecilia Rossi , Natascia Bertoncelli , Martina Buttera , Valeria Capone , Emma Bertucci , Marisa Pugliese , Alberto Berardi

Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) : 1004154

PDF (672KB)
Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) :1004154 DOI: 10.37349/ent.2026.1004154
Case Report
research-article
NEUROD2-related disorder with neonatal onset: case report and review of the literature
Author information +
History +
PDF (672KB)

Abstract

The NEUROD2 gene encodes a transcription factor essential for neuronal differentiation and cortical development. Pathogenic variants cause a rare autosomal dominant neurodevelopmental disorder with variable expressivity, typically presenting in early infancy with developmental delay, epilepsy, and behavioral abnormalities. We report a newborn girl carrying a de novo heterozygous missense variant NM_006160.4:c.790G>A, p.(Ala264Thr), located outside the canonical basic helix-loop-helix (bHLH) domain. Soon after birth, she presented respiratory depression, hypotonia, feeding difficulties, and electrographic seizures. Magnetic resonance imaging (MRI) showed subcortical white matter hyperintensity, and the electroencephalogram (EEG) revealed abnormal background activity. During follow-up, epilepsy was controlled, but neurodevelopmental delay with autistic features emerged. This case represents the earliest reported clinical onset associated with NEUROD2 variants and expands the phenotypic and mutational spectrum. It highlights that variants outside known hotspots can cause severe disease and supports including NEUROD2 in the differential diagnosis of neonatal neurological impairment.

Keywords

NEUROD2 case report / neurodevelopmental disorder / neonatal hypotonia / neonatal seizures / autistic features

Cite this article

Download citation ▾
Licia Lugli, Isotta Guidotti, Cecilia Rossi, Natascia Bertoncelli, Martina Buttera, Valeria Capone, Emma Bertucci, Marisa Pugliese, Alberto Berardi. NEUROD2-related disorder with neonatal onset: case report and review of the literature. Exploration of Neuroprotective Therapy, 2026, 6 (1) : 1004154 DOI:10.37349/ent.2026.1004154

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Bormuth I, Yan K, Yonemasu T, Gummert M, Zhang M, Wichert S, et al. Neuronal basic helix-loop-helix proteins Neurod2/6 regulate cortical commissure formation before midline interactions. J Neurosci. 2013; 33: 641-51.

[2]

Chen F, Moran JT, Zhang Y, Ates KM, Yu D, Schrader LA, et al. The transcription factor NeuroD2 coordinates synaptic innervation and cell intrinsic properties to control excitability of cortical pyramidal neurons. J Physiol. 2016; 594: 3729-44.

[3]

Guzelsoy G, Akkaya C, Atak D, Dunn CD, Kabakcioglu A, Ozlu N, et al. Terminal neuron localization to the upper cortical plate is controlled by the transcription factor NEUROD2. Sci Rep. 2019; 9: 19697.

[4]

Hahn MA, Jin SG, Li AX, Liu J, Huang Z, Wu X, et al. Reprogramming of DNA methylation at NEUROD2-bound sequences during cortical neuron differentiation. Sci Adv. 2019; 5: eaax0080.

[5]

Sega AG, Mis EK, Lindstrom K, Mercimek-Andrews S, Ji W, Cho MT, et al. De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy. J Med Genet. 2019; 56: 113-22.

[6]

Mis EK, Sega AG, Signer RH, Cartwright T, Ji W, Martinez-Agosto JA, et al. Expansion of NEUROD2 phenotypes to include developmental delay without seizures. Am J Med Genet A. 2021; 185: 1076-80.

[7]

Sakpichaisakul K, Boonkrongsak R, Lertbutsayanukul P, Iemwimangsa N, Klumsathian S, Panthan B, et al. Epileptic spasms related to neuronal differentiation factor 2 (NEUROD2) mutation respond to combined vigabatrin and high dose prednisolone therapy. BMC Neurol. 2022; 22: 461.

[8]

Runge K, Mathieu R, Bugeon S, Lafi S, Beurrier C, Sahu S, et al. Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons. Mol Psychiatry. 2021; 26: 6125-48.

[9]

Politano D, Gana S, Pezzotti E, Berardinelli A, Pasca L, Carmen Barbero V, et al. A novel variant in NEUROD2 in a patient with Rett-like phenotype points to Glu130 codon as a mutational hotspot. Brain Dev. 2023; 45: 179-84.

[10]

Poon JYY, Mok MTS, Ho SKL, Cheng SSW, Lo IFM, Luk HM. A de novo pathogenic variant in neuronal differentiation factor 2 in a Chinese patient with early infantile epileptic encephalopathy. Clin Dysmorphol. 2024; 33: 128-33.

[11]

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17: 405-24.

[12]

Whiffin N, Minikel E, Walsh R, O’Donnell-Luria AH, Karczewski K, Ing AY, et al. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet Med. 2017; 19: 1151-8.

[13]

Biesecker LG, Harrison SM ; ClinGen Sequence Variant Interpretation Working Group. The ACMG/AMP reputable source criteria for the interpretation of sequence variants. Genet Med. 2018; 20: 1687-8.

[14]

Lugli L, Bariola MC, Guidotti I, Pugliese M, Roversi MF, Bedetti L, et al. Neurodevelopmental outcome of neonatal seizures: A longitudinal study. Eur J Paediatr Neurol. 2024; 49: 17-26.

[15]

Lugli L, Rossi C, Berardi A, Pugliese M, Ceccarelli PL, Sileo FG, et al. Prenatal multidisciplinary counseling for fetal congenital anomalies: A narrative review. Int J Gynaecol Obstet. 2025; 169: 498-510.

[16]

Stefanski A, Calle-López Y, Leu C, Pérez-Palma E, Pestana-Knight E, Lal D. Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis. Epilepsia. 2021; 62: 143-51.

[17]

Diaz J, Gérard X, Emerit MB, Areias J, Geny D, Dégardin J, et al. YIF1B mutations cause a post-natal neurodevelopmental syndrome associated with Golgi and primary cilium alterations. Brain. 2020; 143: 2911-28.

PDF (672KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉